neoplasia News and Research

RSS

Study forms basis for therapeutic strategies to combat cancers caused by HMGA1a

The researchers led by Professor Raphael Stoll therefore expect their results to form a basis for future therapeutic strategies to combat cancers caused by HMGA1a.

30 Jul 2019

Chronic kidney disease patients are excluded from clinical trials

Kidney diseases affect 850 million people worldwide, a figure twice as high as that of diabetes. Yet patients with chronic kidney disease are still being excluded from clinical trials.

10 Jul 2019

HPV vaccine has led to a dramatic reduction in cervical cancer rates, but Africa is lagging behind

In wealthy countries that have vaccination programs, the HPV vaccine has significantly reduced the rate of HPV-related infections.

4 Jul 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Deletion of ATDC gene prevents development of pancreatic cancer in mice

The action of a gene called ATDC is required for the development of pancreatic cancer, a new study finds.

2 May 2019

Experts in coloproctology will unite to promote global collaboration at 14th Annual ESCP conference

The 14th Annual ESCP conference, which unites global experts in coloproctology, will hear from several prolific key speakers over the course of three days, sharing research, innovation and best practice in Vienna this September.

12 Apr 2019

Pediatric patients undergoing thyroid surgery have better outcomes at high-volume centers

New research recently published in the Journal of Pediatric Surgery found that post-operative success rates of pediatric thyroid patients, particularly children who require a thyroidectomy, correlate with the institution's patient volume.

4 Apr 2019

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

4 Apr 2019

Analysis of cervical precancer shows decline in two strains of HPV

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease.

21 Feb 2019

Therapeutic endoscopy has an expanding role in the treatment of IBD

According to a new statement from a panel of national and international experts in gastroenterology, inflammatory bowel disease (IBD) and other areas, interventional (or therapeutic) IBD endoscopy has an expanding role in the treatment of disease and of adverse events from surgery.

15 Feb 2019

New machine learning method predicts if atypical ductal hyperplasia will turn cancerous

Atypical ductal hyperplasia is a breast lesion associated with a four- to five-fold increase in the risk of breast cancer.

13 Feb 2019

Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations

Colorectal Cancer has now become one of the leading causes of death. Studies indicate that smoking, low physical activities and high-fat diet are a major risk factor for colorectal cancer.

21 Jan 2019

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches the ClearLLab 10C System - the first 10-colour CE-IVD panels of immunophenotyping reagents for lymphoid and myeloid lineages.

From Beckman Coulter Life Sciences - Flow Cytometry 17 Jan 2019

HPV type 16 or 18 associated with cervical cancer risk in young women

The human papilloma virus can cause cervical cancer. According to new guidelines in Sweden, women over thirty therefore undergo initial screening for the virus rather than a smear test.

10 Dec 2018

Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities

Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus types but do not show any signs of cellular abnormalities.

10 Dec 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

HPV vaccination offers best protection against cervical and genital cancers

In low-resource countries without well-developed screening programs, expanding access to human papilloma virus vaccination is the best means of preventing cervical cancer and other diseases caused by HPV infection, according to an editorial in the October special issue of the Journal of Lower Genital Tract Disease, official journal of ASCCP.

28 Sep 2018

Comprehensive analysis informs new recommendation for national cervical cancer screening

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

21 Aug 2018

NCCN releases new treatment guidelines for rare cancers that impact women during pregnancy

The National Comprehensive Cancer Network has released new treatment guidelines for a group of rare cancers that impact women during pregnancy.

10 Aug 2018